Mary-Jane Burkett
Director of Finance/CFO bei NUVO PHARMACEUTICALS INC.
Profil
Mary-Jane E.
Burkett is currently the Chief Financial Officer & Vice President at Nuvo Pharmaceuticals, Inc. She started this position in 2016.
Prior to her current role, she worked as a Controller at Crescita Therapeutics, Inc. Ms. Burkett completed her undergraduate degree at Richard Ivey School of Business.
Aktive Positionen von Mary-Jane Burkett
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | Director of Finance/CFO | 01.09.2016 |
Ehemalige bekannte Positionen von Mary-Jane Burkett
| Unternehmen | Position | Ende |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Mary-Jane Burkett
| Richard Ivey School of Business | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
